drugset / Trial / NCT02706977
The Effect of Dopamine on Diabetic Retinopathy
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the use of electroretinogram (ERG) using a novel handheld system, RETeval, and evaluate contrast sensitivity testing in detecting pre-clinical retinopathy on a tablet device. Investigators also seek to assess if a medication called Sinemet™ CR can improve the electrical functions of the eye in participants with diabetes mellitus. This study will include a total of 45 participants; 30 with diabetes mellitus and 15 age-matched non-diabetic controls. Participants with diabetes mellitus and electroretinogram (ERG) delays will be randomized to a low or high dose Sinemet CR group.
Timeline
- Start
- 2016-01
- Primary completion
- 2019-08-15
- Completion
- 2019-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbidopa | Unknown | 25 mg | Oral |
| Subject | Carbidopa | Unknown | 50 mg | Oral |
| Subject | Levodopa | Small molecule | 100 mg | Oral |
| Subject | Levodopa | Small molecule | 200 mg | Oral |